Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable SMAD binding activity and transcription corepressor activity. Predicted to be involved in several processes, including negative regulation of transcription by RNA polymerase II; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway; and transforming growth factor beta receptor complex assembly. Predicted to be located in nucleus. Predicted to be active in nucleoplasm. Is expressed in several structures, including heart; liver; lung; metanephros; and pancreas. Orthologous to human EID2 (EP300 interacting inhibitor of differentiation 2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.